Clinical Trials Directory

Trials / Conditions / Cervical Cancer Recurrent

Cervical Cancer Recurrent

9 registered clinical trials studyying Cervical Cancer Recurrent — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingHPV After chemoRadioTherapy
NCT07493928
General University Hospital, Prague—
Not Yet RecruitingA Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famiti
NCT07266350
Qi Zhou—
Not Yet RecruitingA Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab fo
NCT07143292
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2
Not Yet RecruitingQL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therap
NCT07141186
Tianjin Medical University Cancer Institute and HospitalPhase 2
RecruitingA Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
NCT06781151
Sun Yat-sen University—
RecruitingEfficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervic
NCT06455046
Fujian Cancer HospitalPhase 2
RecruitingRC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer
NCT06063018
Peking Union Medical College HospitalPhase 2
Active Not RecruitingSBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
NCT03614949
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
UnknownEfficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in
NCT03912402
BiocadPhase 2